Evidence map›Paper›PMID 27933180›Full record

ArticleBMJ open respiratory research2016

Serum levels of immunoglobulins and severity of community-acquired pneumonia.

Mari C de la Torre, Pere Torán, Mateu Serra-Prat, Elisabet Palomera, Estel Güell, Ester Vendrell, Joan Carles Yébenes, Antoni Torres, Jordi Almirall

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia.African journal of thoracic and critical care medicine · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mari C de la TorreCritical Care Unit , Hospital de Mataró, Universitat Autònoma de Barcelona, Ciber Enfermedades Respiratorias, CIBERES , Barcelona , Spain.
Pere ToránUnitat Suport Recerca Metropolitana Nord ICS, Santa Coloma de Gramanet , Barcelona , Spain.
Mateu Serra-PratResearch Unit , Hospital de Mataró, CIBEREHD , Barcelona , Spain.
Elisabet PalomeraResearch Unit , Hospital de Mataró, CIBEREHD , Barcelona , Spain.
Estel GüellDepartment of Biochemistry , Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró , Barcelona , Spain.
Ester VendrellDepartment of Biochemistry , Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró , Barcelona , Spain.
Joan Carles YébenesDepartment of Biochemistry , Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró , Barcelona , Spain.
Antoni TorresService of Pneumology , Institut Clínic del Torax, IDIBAPS, Hospital Clínic de Barcelona, Universitat de Barcelona, CIBERES , Barcelona , Spain.
Jordi AlmirallDepartment of Biochemistry , Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró , Barcelona , Spain.
Universitat Autònoma de Barcelona · ESHospital de Mataró · ESHospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

instructionThere is evidence of a relationship between severity of infection and inflammatory response of the immune system. The objective is to assess serum levels of immunoglobulins and to establish its relationship with severity of community-acquired pneumonia (CAP) and clinical outcome.

methodsThis was an observational and cross-sectional study in which 3 groups of patients diagnosed with CAP were compared: patients treated in the outpatient setting (n=54), patients requiring in-patient care (hospital ward) (n=173), and patients requiring admission to the intensive care unit (ICU) (n=191).

resultsSerum total IgG (and IgG subclasses IgG1, IgG2, IgG3, IgG4), IgA and IgM were measured at the first clinical visit. Normal cutpoints were defined as the lowest value obtained in controls (≤680, ≤323, ≤154, ≤10, ≤5, ≤30 and ≤50 mg/dL for total IgG, IgG1, IgG2, IgG3, IgG4, IgM and IgA, respectively). Serum immunoglobulin levels decreased in relation to severity of CAP. Low serum levels of total IgG, IgG1 and IgG2 showed a relationship with ICU admission. Low serum level of total IgG was independently associated with ICU admission (OR=2.45, 95% CI 1.4 to 4.2, p=0.002), adjusted by the CURB-65 severity score and comorbidities (chronic respiratory and heart diseases). Low levels of total IgG, IgG1 and IgG2 were significantly associated with 30-day mortality.

conclusionsPatients with severe CAP admitted to the ICU showed lower levels of immunoglobulins than non-ICU patients and this increased mortality.

Indexed as

ImmunodeficiencyPneumoniaRespiratory Infection

Identifiers

PMID27933180
PMCPMC5133423
OpenAlexW2557430728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.